Literature DB >> 29746807

Management of In-Transit Melanoma: We Need Some High-Quality Data.

David E Gyorki1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29746807     DOI： 10.1200/JOP.18.00215

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  1 in total

1.  Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany.

Authors:  Julia Maria Ressler; Matthias Karasek; Lukas Koch; Rita Silmbrod; Joanna Mangana; Sofiya Latifyan; Veronica Aedo-Lopez; Helmut Kehrer; Felix Weihsengruber; Peter Koelblinger; Christian Posch; Julian Kofler; Olivier Michielin; Erika Richtig; Christine Hafner; Christoph Hoeller
Journal:  J Immunother Cancer       Date:  2021-02       Impact factor: 13.751
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.